The table below shows Oruka Therapeutics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$23.58M
-$20.87M
-$1.53M
-$1.59M
-$4.30M
-$5.22M
Capital expenditure
$73.00K
$13.00K
-
-
$2.00K
$6.00K
Investing cash flow
-$14.44M
$42.87M
$0.00
$0.00
-$2.00K
-$6.00K
Dividends paid
-
-
-
-
ORKA operating cash flow (10-K history)
Oruka Therapeutics, Inc. reported operating cash flow of -$88.21M for fiscal year 2025. That is down 52.5% from -$57.84M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$5.29M (FY 2013) to -$88.21M. Figures come from the company's audited annual reports as filed with the SEC.